Benjamin A. Sherer

University of California, San Francisco

Papers

1

Total Citations

62

H-Index

1

About

Benjamin A. Sherer is a leading urologic oncologist whose research has significantly advanced the surgical management of kidney cancer. His primary focus lies in comparing minimally invasive techniques—particularly robotic-assisted surgery—against traditional open approaches to optimize patient outcomes. Sherer’s landmark work, the systematic review and meta-analysis “Open versus robotic partial nephrectomy,” has been cited over 60 times, establishing a critical evidence base that demonstrates robotic partial nephrectomy offers comparable oncologic efficacy with reduced blood loss and shorter hospital stays. This study has become a cornerstone reference for surgeons and institutions adopting robotic platforms. Beyond this, Sherer has contributed to refining nephron-sparing surgery protocols and evaluating long-term functional outcomes. His research bridges the gap between surgical innovation and clinical practice, helping to standardize care for renal masses. Recognized for his rigorous methodology and translational impact, Sherer’s work continues to shape guidelines and training in urologic oncology, making him a trusted voice for students and clinicians navigating the evolving landscape of kidney cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
62
Total Citations
62
Avg Citations/Paper
🏆 Most Cited Paper
Open versus robotic partial nephrectomy: Systematic review and meta‐analysis of contemporary studies
62 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago